PHARMACEUTICALLY ACTIVE MORPHOLINOL

Disclosed is the compound (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol and pharmaceutically acceptable salts and solvates thereof, pharmaceutical compositions comprising them; also disclosed is a method of treating depression, attention deficit hyperactivity disorder (ADHD), obesity, migraine, pain, sexual dysfunction, Parkinson's disease, Alzheimer's disease, or addiction to cocaine or nicotine-containing (especially tobacco) products using such compound, salts, solvates or compositions. Opisano je jedinjenje (+)-(2S,3S)-2-(3-hlorofenil)-3,5,5-trimetil-2-morfolinol i njegove farmaceutski prihvatljive soli i solvati, farmaceutski preparati koji ih sadrže, a takodje je opisan i postupak tretiranja depresije, poremećaja hiperaktivnosti sa smanjivanjem pažnje (ADHD), gojaznosti, migrene, bola, seksualne disfunkcije, Parkinsonove bolesti, Alchajmerove bolesti, zavisnosti od kokaina ili od proizvoda koji sadrže nikotin (naročito duvan) korišćenjem ovog jedinjenja, njegovih soli, solvata i preparata.[Disclosed is the compound (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol and pharmaceutically acceptable salts and solvates thereof, pharmaceutical compositions comprising them; also disclosed is a method of treating depression, attention deficit hyperactivity disorder (ADHD), obesity, migraine, pain, sexual dysfunction, Parkinson's disease, Alzheimer's disease, or addiction to cocaine or nicotine-containing (especially tobacco) products using such compound, salts, solvates or compositions.